These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38692467)

  • 1. Deciphering the pancreatic cancer microbiome in Mainland China: Impact of Exiguobacterium/Bacillus ratio on tumor progression and prognostic significance.
    Zhang Z; Wang T; Xu M; Zhang Z; Wang H; Xue J; Wang W
    Pharmacol Res; 2024 Jun; 204():107197. PubMed ID: 38692467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the bile microbiome is associated with progression-free survival in pancreatic ductal adenocarcinoma patients.
    Jiang H; Tian Y; Xu L; Chen X; Huang Y; Wu J; Wang T; Liu T; Wu X; Ye C; Wu H; Ye W; Fang L; Zhang Y
    BMC Microbiol; 2024 Jul; 24(1):235. PubMed ID: 38956452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
    Riquelme E; Zhang Y; Zhang L; Montiel M; Zoltan M; Dong W; Quesada P; Sahin I; Chandra V; San Lucas A; Scheet P; Xu H; Hanash SM; Feng L; Burks JK; Do KA; Peterson CB; Nejman D; Tzeng CD; Kim MP; Sears CL; Ajami N; Petrosino J; Wood LD; Maitra A; Straussman R; Katz M; White JR; Jenq R; Wargo J; McAllister F
    Cell; 2019 Aug; 178(4):795-806.e12. PubMed ID: 31398337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.
    Thomas RM; Gharaibeh RZ; Gauthier J; Beveridge M; Pope JL; Guijarro MV; Yu Q; He Z; Ohland C; Newsome R; Trevino J; Hughes SJ; Reinhard M; Winglee K; Fodor AA; Zajac-Kaye M; Jobin C
    Carcinogenesis; 2018 Jul; 39(8):1068-1078. PubMed ID: 29846515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.
    Chu CS; Yang CY; Yeh CC; Lin RT; Chen CC; Bai LY; Hung MC; Lin CC; Wu CY; Lin JT
    Sci Rep; 2022 Jan; 12(1):107. PubMed ID: 34997106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of biliary stent and neoadjuvant chemotherapy in the pancreatic tumor microbiome.
    Nalluri H; Jensen E; Staley C
    BMC Microbiol; 2021 Oct; 21(1):280. PubMed ID: 34656097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
    Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
    Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition.
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA;
    Cancer Res; 2021 Jul; 81(13):3461-3479. PubMed ID: 33980655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives.
    Tabrizi E; Pourteymour Fard Tabrizi F; Mahmoud Khaled G; Sestito MP; Jamie S; Boone BA
    Front Immunol; 2024; 15():1434771. PubMed ID: 39044834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumor Microbiome Analysis Identifies Positive Association Between
    Huang Y; Zhu N; Zheng X; Liu Y; Lu H; Yin X; Hao H; Tan Y; Wang D; Hu H; Liang Y; Li X; Hu Z; Yin Y
    Front Immunol; 2022; 13():785422. PubMed ID: 35145519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.
    Tang R; Liu X; Liang C; Hua J; Xu J; Wang W; Meng Q; Liu J; Zhang B; Yu X; Shi S
    Front Immunol; 2021; 12():648917. PubMed ID: 33777046
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Maddalena M; Mallel G; Nataraj NB; Shreberk-Shaked M; Hassin O; Mukherjee S; Arandkar S; Rotkopf R; Kapsack A; Lambiase G; Pellegrino B; Ben-Isaac E; Golani O; Addadi Y; Hajaj E; Eilam R; Straussman R; Yarden Y; Lotem M; Oren M
    Proc Natl Acad Sci U S A; 2021 Jun; 118(23):. PubMed ID: 34088837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral microbiota of pancreatic ductal adenocarcinoma impact patient prognosis by influencing tumor microenvironment.
    Leng J; Xu H; Liu X; Yang Y; Ning C; Sun L; Qu J; Ke X; Lan X
    Discov Oncol; 2024 Sep; 15(1):443. PubMed ID: 39271584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
    Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
    J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma.
    Abe S; Masuda A; Matsumoto T; Inoue J; Toyama H; Sakai A; Kobayashi T; Tanaka T; Tsujimae M; Yamakawa K; Gonda M; Masuda S; Uemura H; Kohashi S; Inomata N; Nagao K; Harada Y; Miki M; Irie Y; Juri N; Ko T; Yokotani Y; Oka Y; Ota S; Kanzawa M; Itoh T; Imai T; Fukumoto T; Hara E; Kodama Y
    J Gastroenterol; 2024 Mar; 59(3):250-262. PubMed ID: 38242997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
    Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
    Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma.
    Pfisterer N; Ammer-Herrmenau C; Antweiler K; Küffer S; Ellenrieder V; Neesse A
    Pancreatology; 2023 Sep; 23(6):663-673. PubMed ID: 37541802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
    Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
    Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.